We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Clearstream | LSE:CTN | London | Ordinary Share | IE00B03QHM52 | ORD EUR0.125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
21/2/2011 12:44 | Yes thanks for that 2vdm. S. we havn't been too hot on the football front this season, but entertain Cam utd tuesday eve, a must win for us> | hastings | |
21/2/2011 10:16 | This was emailed out from UK Analyst (owned by T1ps) yesterday in a genearl article about the drivers behind rising biotechs. Hope it's of interest:- "Medical devices manufacturer Clearstream recently signed a 25-year lease on an additional 19,000 square ft facility immediately adjacent to its current facility in Enniscorthy, County Wexford, Ireland. All customer facing functions and R&D will relocate to the new facility where a new R&D lab will also be built, and the expansion of capacity sets the company in good stead to respond to the growing level of demand for its products in 2011. Sales of co-labelled peripheral products grew by 65% in the second half, and this trend should continue in 2011 as new products are launched. Whilst the launch of the new facility is likely to entail at least 2.8 million euros of capital expenditure over the next 18 months as the facility is developed, margins are expected to remain in the low 40% range as peripherals continue to play a greater role in the sales mix. Longer term, the new facility should enable the company to sustain the momentum it has built within its BRIC markets, particularly China and Brazil. Trading on a current (July 2011) rating of 14.2 falling to 7.1 for 2012, Clearstream shares offer material upside through a market exposed to long-term structural growth drivers" | 2vdm | |
21/2/2011 08:47 | It'll be interesting to see how your estimate compares. Three years back, a current PER 15 would have been now problem given the forecast growth rate, now though the Mkt seems understandably more cautious. I can see the share price progressing further towards 60p, but suspect that it might linger in the 60s until we receive further news on trading that, if sufficiently positive, could see a further marked rise towards year end. One thing's for certain, the Company are operating in a sector driven by necessity rather than discretionary spending and that should ensure good turnover providing that the products perform well and offer opportunities for expansion of their range. Hastings, that's good to know. Your football team's exploits put the town firmly on the map. | spaceparallax | |
19/2/2011 14:47 | Estimate of 2011 figs. From previous Interm and Final results Interms loss .7m Finals profit .5m Also stated 4th qtr 25% greater than 3rd qtr Using above 1st and 2nd qtrs -.7m 3rd and 4th qtrs profit 1.2m to give finals of .5m again from above 4th qtr was 25% greater than 3rd this equates to 3rd qtr .533m 4th qtr .666m (total 1.2m) Using 4th qtr as bases for 2011 forecast =.666m *4 = 2.666m eur say growth 20% = 3.197m eur from finals .5m =eps of 1.12c therefore 3.197m = eps of 6.394c (eur) or 5.4p eps Say PER of 15 = 81p share price Dec 2011 Comments welcome | ianst99 | |
19/2/2011 09:26 | That where i reside S, so know Walden fairly well, lovely place. | hastings | |
19/2/2011 09:10 | I'm not that far from Histon, but don't know it well | spaceparallax | |
18/2/2011 23:30 | Good finish S, by the way, do you know of Histon!!! | hastings | |
18/2/2011 15:39 | A healthy trading volume today - presumably going to close somewhere C250K. | spaceparallax | |
18/2/2011 13:53 | It might be old news but this was tipped in 'shares' mag last week as one of 20 AIM stocks to watch. Indeed thats how ive come to this co. Waiting for a decent entry point today hopefully, and hopefully a run up to 60p soon. dd | ddinksdadd | |
18/2/2011 13:28 | I see we have a little PTing - in some respects understandable, although given that we've broken out I suspect those concerned could be leaving a handsome chunk on the table. | spaceparallax | |
18/2/2011 13:12 | Very nice movement today and no more than the stock deserves. Interesting what you say about 2013 S, and a very valid point. Mkt Cap is still very much on the low side given growth in both sales and profit. | hastings | |
18/2/2011 12:22 | Cheers ST. If you receive that paper, then we live pretty close by - I'm in sleepy Saffron Walden. | spaceparallax | |
18/2/2011 12:05 | Was tipped in cambridge-news.co.uk but doubt that has reached the masses! LOL "I make no apologies for mentioning ClearStream Technologies again, as the company issued a solid trading update last week. Despite closing at 45p, I feel the party is just beginning here and a sustained run should be on the cards." | stocktrawler | |
18/2/2011 11:58 | lovely vertical surge - I'm beginning to suspect that we've been tipped again. Anyone know if that's the case? | spaceparallax | |
18/2/2011 10:40 | The nice, steady trickle of buys continues and we're looking to have broken out - can't be long before we break 50p. I suspect it's the combination of good newsflow and ultralow PEG that's turning investors heads - it'll be very interesting to see the FY13 forecast. | spaceparallax | |
17/2/2011 13:54 | There's obviously still interest | spaceparallax | |
17/2/2011 13:13 | Wonder if we might see another decent Buy come through today. | hastings | |
16/2/2011 14:19 | Just a small snippet of US news could help this break through the 46p resistance. | spaceparallax | |
14/2/2011 13:31 | Indeed, pretty much supports our layman's analysis | spaceparallax | |
14/2/2011 12:25 | HB from 10/2 Clearstream (CTN, 39.25p, £18.09m) Trading update from the medical devices specialist for the six months ending January 2011 confirms continued healthy trading. The group believes the first half results are comfortably in-line with market expectations for the year to August (£1.1m PBT with 3.8p EPS). Not only have capacity increases been achieved but he group also expects to add another product line in the next quarter to the 9 already in-place. With traditionally stronger H2 trading expected and increased capacity we are happy to reconfirm our BUY stance with a 48p fair value which we expect to increase dramatically as investors focus on next year. (Julian Tolley) | stegrego |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions